Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Hemodynamic-GUIDEd management of Heart Failure (GUIDE-HF).

Lindenfeld J, Abraham WT, Maisel A, Zile M, Smart F, Costanzo MR, Mehra MR, Ducharme A, Sears SF, Desai AS, Paul S, Sood P, Johnson N, Ginn G, Adamson PB.

Am Heart J. 2019 Aug;214:18-27. doi: 10.1016/j.ahj.2019.04.014. Epub 2019 May 3. No abstract available.

2.

The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study.

Tremblay-Gravel M, Marquis-Gravel G, Avram R, Desplantie O, Ducharme A, Bibas L, Pacheco C, Couture E, Simard F, Poulin A, Malhamé I, Tran D, Rey E, Tournoux F, Harvey L, Sénéchal M, Bélisle P, Descarries L, Farand P, Pranno N, Diaz A, Afilalo J, Ly HQ, Fortier A, Jolicoeur EM; BRO-HF investigators.

ESC Heart Fail. 2019 Feb;6(1):27-36. doi: 10.1002/ehf2.12376. Epub 2018 Nov 22.

3.

Temporal Changes on the Risks and Complications of Posttransplantion Diabetes Mellitus Following Cardiac Transplantation.

Iannino N, Nasri A, Räkel A, Ducharme A, Lachance K, Racine N, de Denus S, Tremblay-Gravel M, Fortier A, White M.

J Transplant. 2018 Nov 8;2018:9205083. doi: 10.1155/2018/9205083. eCollection 2018.

4.

Setting Up a Heart Failure Program in 2018: Moving Towards New Paradigm(s).

Bouabdallaoui N, Ducharme A.

Curr Heart Fail Rep. 2018 Dec;15(6):357-367. doi: 10.1007/s11897-018-0412-x. Review.

PMID:
30251188
5.

Aortic regurgitation in patients with a left ventricular assist device: A contemporary review.

Bouabdallaoui N, El-Hamamsy I, Pham M, Giraldeau G, Parent MC, Carrier M, Rouleau JL, Ducharme A.

J Heart Lung Transplant. 2018 Nov;37(11):1289-1297. doi: 10.1016/j.healun.2018.07.002. Epub 2018 Sep 7.

PMID:
30197211
6.

A comparison of the effects of selective and non-selective mineralocorticoid antagonism on glucose homeostasis of heart failure patients with glucose intolerance or type II diabetes: A randomized controlled double-blind trial.

Korol S, White M, O'Meara E, Tournoux F, Racine N, Ducharme A, Rouleau JL, Liszkowski M, Mansour A, Jutras M, Guertin MC, Bernier M, Lavoie J, Leclair G, Neagoe PE, Chaar D, Sirois MG, de Denus S.

Am Heart J. 2018 Oct;204:190-195. doi: 10.1016/j.ahj.2018.07.002. Epub 2018 Jul 10.

PMID:
30097164
7.

Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.

Halbach M, Abraham WT, Butter C, Ducharme A, Klug D, Little WC, Reuter H, Schafer JE, Senni M, Swarup V, Wachter R, Weaver FA, Wilks SJ, Zile MR, Müller-Ehmsen J.

Int J Cardiol. 2018 Sep 1;266:187-192. doi: 10.1016/j.ijcard.2018.04.075. Epub 2018 Apr 21.

PMID:
29705650
8.

A prospective study of the impact of AGTR1 A1166C on the effects of candesartan in patients with heart failure.

de Denus S, Dubé MP, Fouodjio R, Huynh T, LeBlanc MH, Lepage S, Sheppard R, Giannetti N, Lavoie J, Mansour A, Provost S, Normand V, Mongrain I, Langlois M, O'Meara E, Ducharme A, Racine N, Guertin MC, Turgeon J, Phillips MS, Rouleau JL, Tardif JC, White M; CANDIID II investigators.

Pharmacogenomics. 2018 May;19(7):599-612. doi: 10.2217/pgs-2018-0004. Epub 2018 Apr 27.

PMID:
29701105
9.

Pregnancy after heart transplantation: a well-thought-out decision? The Quebec provincial experience - a multi-centre cohort study.

Dagher O, Alami Laroussi N, Carrier M, Cecere R, Charbonneau E, de Denus S, Giannetti N, Leduc L, Cantin B, Mansour A, Poirier N, Raboisson MJ, White M, Ducharme A.

Transpl Int. 2018 Feb 26. doi: 10.1111/tri.13144. [Epub ahead of print]

10.

Changes in Outcomes of Cardiac Allograft Vasculopathy Over 30 Years Following Heart Transplantation.

Tremblay-Gravel M, Racine N, de Denus S, Ducharme A, Pelletier GB, Giraldeau G, Liszkowski M, Parent MC, Carrier M, Fortier A, White M.

JACC Heart Fail. 2017 Dec;5(12):891-901. doi: 10.1016/j.jchf.2017.09.014.

11.

The Need for Heart Failure Advocacy in Canada.

Virani SA, Bains M, Code J, Ducharme A, Harkness K, Howlett JG, Ross H, Sussex B, Zieroth S; Board and Membership of the Canadian Heart Failure Society.

Can J Cardiol. 2017 Nov;33(11):1450-1454. doi: 10.1016/j.cjca.2017.08.024. Epub 2017 Sep 11. No abstract available.

PMID:
29111108
12.

2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure.

Ezekowitz JA, O'Meara E, McDonald MA, Abrams H, Chan M, Ducharme A, Giannetti N, Grzeslo A, Hamilton PG, Heckman GA, Howlett JG, Koshman SL, Lepage S, McKelvie RS, Moe GW, Rajda M, Swiggum E, Virani SA, Zieroth S, Al-Hesayen A, Cohen-Solal A, D'Astous M, De S, Estrella-Holder E, Fremes S, Green L, Haddad H, Harkness K, Hernandez AF, Kouz S, LeBlanc MH, Masoudi FA, Ross HJ, Roussin A, Sussex B.

Can J Cardiol. 2017 Nov;33(11):1342-1433. doi: 10.1016/j.cjca.2017.08.022. Epub 2017 Sep 6.

PMID:
29111106
13.

Impact of Left Ventricular vs Biventricular Pacing on Reverse Remodelling: Insights From the Evaluation of Resynchronization Therapy for Heart Failure (EARTH) Trial.

Skaf S, Thibault B, Khairy P, O'Meara E, Fortier A, Vakulenko HV, Pitre C, White M, Ducharme A; EARTH Investigators.

Can J Cardiol. 2017 Oct;33(10):1274-1282. doi: 10.1016/j.cjca.2017.07.478. Epub 2017 Jul 31.

PMID:
28941607
14.

Experience with the SynCardia total artificial heart in a Canadian centre.

Nguyen A, Pellerin M, Perrault LP, White M, Ducharme A, Racine N, Carrier M.

Can J Surg. 2017 Dec;60(6):375-379.

15.

Do Heart Failure Clinics Have to Reinvent Themselves to Remain Germane?

Ducharme A.

Can J Cardiol. 2017 Oct;33(10):1212-1214. doi: 10.1016/j.cjca.2017.07.003. Epub 2017 Jul 17. No abstract available.

PMID:
28822652
16.

Changes in patient characteristics following cardiac transplantation: the Montreal Heart Institute experience.

Vistarini N, Nguyen A, White M, Racine N, Perrault LP, Ducharme A, Bouchard D, Demers P, Pellerin M, Lamarche Y, El-Hamamsy I, Giraldeau G, Pelletier G, Carrier M.

Can J Surg. 2017 Sep;60(5):305-310.

17.

Circulating acylcarnitine profile in human heart failure: a surrogate of fatty acid metabolic dysregulation in mitochondria and beyond.

Ruiz M, Labarthe F, Fortier A, Bouchard B, Thompson Legault J, Bolduc V, Rigal O, Chen J, Ducharme A, Crawford PA, Tardif JC, Des Rosiers C.

Am J Physiol Heart Circ Physiol. 2017 Oct 1;313(4):H768-H781. doi: 10.1152/ajpheart.00820.2016. Epub 2017 Jul 14.

18.

Barriers to Goals of Care Discussions With Patients Who Have Advanced Heart Failure: Results of a Multicenter Survey of Hospital-Based Cardiology Clinicians.

You JJ, Aleksova N, Ducharme A, MacIver J, Mielniczuk L, Fowler RA, Demers C, Clarke B, Parent MC, Toma M, Strachan PH, Farand P, Isaac D, Zieroth S, Swinton M, Jiang X, Day AG, Heyland DK, Ross HJ.

J Card Fail. 2017 Nov;23(11):786-793. doi: 10.1016/j.cardfail.2017.06.003. Epub 2017 Jun 23.

PMID:
28648852
19.

Collectively Operated Fellow-Initiated Research as a Novel Teaching Model to Bolster Interest and Increase Proficiency in Academic Research.

Marquis-Gravel G, Avram R, Tremblay-Gravel M, Desplantie O, Ly HQ, Ducharme A, Jolicoeur EM; BRO-HF Initiative Investigators.

Can J Cardiol. 2017 May;33(5):685-687. doi: 10.1016/j.cjca.2017.01.012. Epub 2017 Jan 24.

PMID:
28449840
20.

Multicenter evaluation of a national organ sharing policy for highly sensitized patients listed for heart transplantation in Canada.

Clarke B, Ducharme A, Giannetti N, Kim D, McDonald M, Pflugfelder P, Rajda M, Sénéchal M, Stadnick E, Toma M, Zieroth S, Isaac D.

J Heart Lung Transplant. 2017 May;36(5):491-498. doi: 10.1016/j.healun.2017.01.003. Epub 2017 Jan 6.

PMID:
28162932
21.

Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction.

Weaver FA, Abraham WT, Little WC, Butter C, Ducharme A, Halbach M, Klug D, Lovett EG, Madershahian N, Müller-Ehmsen J, Schafer JE, Senni M, Swarup V, Wachter R, Zile MR.

Semin Thorac Cardiovasc Surg. 2016 Summer;28(2):320-328. doi: 10.1053/j.semtcvs.2016.04.017. Epub 2016 Jun 2.

22.

Preoperative Optimization of the Heart Failure Patient Undergoing Cardiac Surgery.

Pichette M, Liszkowski M, Ducharme A.

Can J Cardiol. 2017 Jan;33(1):72-79. doi: 10.1016/j.cjca.2016.08.004. Epub 2016 Aug 6. Review.

PMID:
27876563
23.

Clinical outcomes and economic impact of transcatheter mitral leaflet repair in heart failure patients.

Asgar AW, Khairy P, Guertin MC, Cournoyer D, Ducharme A, Bonan R, Basmadjian A, Tardif JC, Cohen DJ.

J Med Econ. 2017 Jan;20(1):82-90. Epub 2016 Sep 21.

PMID:
27552378
24.

Impact of left ventricular function on clinical outcomes of functional mitral regurgitation patients undergoing transcatheter mitral valve repair.

Azzalini L, Millán X, Khan R, Couture P, Ducharme A, Basmadjian A, Bonan R, Asgar AW.

Catheter Cardiovasc Interv. 2016 Dec;88(7):1124-1133. doi: 10.1002/ccd.26460. Epub 2016 Feb 19.

PMID:
26891711
25.

The Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice.

Howlett JG, Chan M, Ezekowitz JA, Harkness K, Heckman GA, Kouz S, Leblanc MH, Moe GW, O'Meara E, Abrams H, Ducharme A, Grzeslo A, Hamilton PG, Koshman SL, Lepage S, McDonald M, McKelvie R, Rajda M, Swiggum E, Virani S, Zieroth S; Canadian Cardiovascular Society Heart Failure Guidelines Panels.

Can J Cardiol. 2016 Mar;32(3):296-310. doi: 10.1016/j.cjca.2015.06.019. Epub 2015 Jun 25. Review.

PMID:
26391749
26.

Very Low Ventricular Pacing Rates Can Be Achieved Safely in a Heterogeneous Pacemaker Population and Provide Clinical Benefits: The CANadian Multi-Centre Randomised Study-Spontaneous AtrioVEntricular Conduction pReservation (CAN-SAVE R) Trial.

Thibault B, Ducharme A, Baranchuk A, Dubuc M, Dyrda K, Guerra PG, Macle L, Mondésert B, Rivard L, Roy D, Talajic M, Andrade J, Nitzsché R, Khairy P; CAN‐SAVE R Study Investigators.

J Am Heart Assoc. 2015 Jul 23;4(7). pii: e001983. doi: 10.1161/JAHA.115.001983.

27.

The Medical Treatment of New-Onset Peripartum Cardiomyopathy: A Systematic Review of Prospective Studies.

Desplantie O, Tremblay-Gravel M, Avram R, Marquis-Gravel G, Ducharme A, Jolicoeur EM; BRO-HF Initiative Investigators.

Can J Cardiol. 2015 Dec;31(12):1421-6. doi: 10.1016/j.cjca.2015.04.029. Epub 2015 May 2. Review.

PMID:
26160409
28.

Late Infection of an Atrial Septal Defect Closure Device: A Possible Complication.

Thibodeau-Jarry N, Ibrahim R, Ducharme A, Sia YT.

Can J Cardiol. 2015 Sep;31(9):1204.e9-11. doi: 10.1016/j.cjca.2015.01.043. Epub 2015 Feb 17.

PMID:
26048554
29.

Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.

Zile MR, Abraham WT, Weaver FA, Butter C, Ducharme A, Halbach M, Klug D, Lovett EG, Müller-Ehmsen J, Schafer JE, Senni M, Swarup V, Wachter R, Little WC.

Eur J Heart Fail. 2015 Oct;17(10):1066-74. doi: 10.1002/ejhf.299. Epub 2015 Jun 10.

30.

Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.

Abraham WT, Zile MR, Weaver FA, Butter C, Ducharme A, Halbach M, Klug D, Lovett EG, Müller-Ehmsen J, Schafer JE, Senni M, Swarup V, Wachter R, Little WC.

JACC Heart Fail. 2015 Jun;3(6):487-496. doi: 10.1016/j.jchf.2015.02.006. Epub 2015 May 14.

31.

Decreased circulating and neutrophil mediated VEGF-A165 release in stable long-term cardiac transplant recipients.

Vitiello D, Chaar D, Neagoe PE, Ducharme A, Carrier M, Pelletier GB, Racine N, Liszkowski M, Sirois MG, White M.

Vasc Cell. 2015 Apr 22;7:4. doi: 10.1186/s13221-015-0029-8. eCollection 2015.

32.

Management of the extravasation of anti-neoplastic agents.

Boulanger J, Ducharme A, Dufour A, Fortier S, Almanric K; Comité de l’évolution de la pratique des soins pharmaceutiques (CEPSP); Comité de l’évolution des pratiques en oncologie (CEPO).

Support Care Cancer. 2015 May;23(5):1459-71. doi: 10.1007/s00520-015-2635-7. Epub 2015 Feb 26. Review.

PMID:
25711653
33.

The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implications.

Moe GW, Ezekowitz JA, O'Meara E, Lepage S, Howlett JG, Fremes S, Al-Hesayen A, Heckman GA, Abrams H, Ducharme A, Estrella-Holder E, Grzeslo A, Harkness K, Koshman SL, McDonald M, McKelvie R, Rajda M, Rao V, Swiggum E, Virani S, Zieroth S, Arnold JM, Ashton T, D'Astous M, Chan M, De S, Dorian P, Giannetti N, Haddad H, Isaac DL, Kouz S, Leblanc MH, Liu P, Ross HJ, Sussex B, White M; Canadian Cardiovascular Society.

Can J Cardiol. 2015 Jan;31(1):3-16. doi: 10.1016/j.cjca.2014.10.022. Epub 2014 Dec 19. Erratum in: Can J Cardiol. 2016 Mar;32(3):394.

PMID:
25532421
34.

The epidemic of heart failure: a lucid approach to stemming the rising tide.

O'Meara E, Thibodeau-Jarry N, Ducharme A, Rouleau JL.

Can J Cardiol. 2014 Dec;30(12 Suppl):S442-54. doi: 10.1016/j.cjca.2014.09.032. Epub 2014 Oct 2. Review.

PMID:
25448464
35.

MitraClip intervention as rescue therapy in cardiogenic shock: one-year follow-up.

Couture P, Cloutier-Gill LA, Ducharme A, Bonan R, Asgar AW.

Can J Cardiol. 2014 Sep;30(9):1108.e15-6. doi: 10.1016/j.cjca.2014.03.045. Epub 2014 May 6.

PMID:
25151290
36.

Heart failure with anemia: novel findings on the roles of renal disease, interleukins, and specific left ventricular remodeling processes.

O'Meara E, Rouleau JL, White M, Roy K, Blondeau L, Ducharme A, Neagoe PE, Sirois MG, Lavoie J, Racine N, Liszkowski M, Madore F, Tardif JC, de Denus S; ANCHOR Investigators.

Circ Heart Fail. 2014 Sep;7(5):773-81. doi: 10.1161/CIRCHEARTFAILURE.114.001100. Epub 2014 Jul 15.

PMID:
25027873
37.

Opinions, hopes and concerns regarding pharmacogenomics: a comparison of healthy individuals, heart failure patients and heart transplant recipients.

Lachance K, Korol S, O'Meara E, Ducharme A, Racine N, Liszkowski M, Rouleau JL, Pelletier GB, Carrier M, White M, de Denus S.

Pharmacogenomics J. 2015 Feb;15(1):13-9. doi: 10.1038/tpj.2014.29. Epub 2014 Jul 1.

PMID:
24980785
38.

Long-term evolution, secular trends, and risk factors of renal dysfunction following cardiac transplantation.

Lachance K, White M, Carrier M, Mansour A, Racine N, Liszkowski M, Ducharme A, de Denus S.

Transpl Int. 2014 Aug;27(8):824-37. doi: 10.1111/tri.12340. Epub 2014 May 26.

39.

Sirolimus Immunoprophylaxis and Renal Histological Changes in Long-Term Cardiac Transplant Recipients: A Pilot Study.

White M, Boucher A, Dandavino R, Fortier A, Pelletier GB, Racine N, Ducharme A, de Denus S, Carrier M, Collette S.

Ann Pharmacother. 2014 Jul;48(7):837-846. Epub 2014 Apr 16.

PMID:
24740466
40.

Changes in cardiopulmonary reserve and peripheral arterial function concomitantly with subclinical inflammation and oxidative stress in patients with heart failure with preserved ejection fraction.

Vitiello D, Harel F, Touyz RM, Sirois MG, Lavoie J, Myers J, Ducharme A, Racine N, O'Meara E, Gayda M, Chabot-Blanchet M, Rouleau JL, de Denus S, White M.

Int J Vasc Med. 2014;2014:917271. doi: 10.1155/2014/917271. Epub 2014 Feb 27.

41.

Prognostic value of the physical examination in patients with heart failure and atrial fibrillation: insights from the AF-CHF trial (atrial fibrillation and chronic heart failure).

Caldentey G, Khairy P, Roy D, Leduc H, Talajic M, Racine N, White M, O'Meara E, Guertin MC, Rouleau JL, Ducharme A.

JACC Heart Fail. 2014 Feb;2(1):15-23. doi: 10.1016/j.jchf.2013.10.004. Epub 2014 Jan 8.

42.

Circulating levels of linoleic acid and HDL-cholesterol are major determinants of 4-hydroxynonenal protein adducts in patients with heart failure.

Asselin C, Ducharme A, Ntimbane T, Ruiz M, Fortier A, Guertin MC, Lavoie J, Diaz A, Levy E, Tardif JC, Des Rosiers C.

Redox Biol. 2013 Dec 18;2:148-55. doi: 10.1016/j.redox.2013.12.009. eCollection 2014.

43.

The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: focus on rehabilitation and exercise and surgical coronary revascularization.

Canadian Cardiovascular Society Heart Failure Management Primary Panel, Moe GW, Ezekowitz JA, O'Meara E, Howlett JG, Fremes SE, Al-Hesayen A, Heckman GA, Ducharme A, Estrella-Holder E, Grzeslo A, Harkness K, Lepage S, McDonald M, McKelvie RS, Nigam A, Rajda M, Rao V, Swiggum E, Virani S, Van Le V, Zieroth S; Canadian Cardiovascular Society Heart Failure Management Secondary Panel, Arnold JM, Ashton T, D'Astous M, Dorian P, Giannetti N, Haddad H, Isaac DL, Kouz S, Leblanc MH, Liu P, Ross HJ, Sussex B, White M.

Can J Cardiol. 2014 Mar;30(3):249-63. doi: 10.1016/j.cjca.2013.10.010. Epub 2013 Oct 19. Review.

PMID:
24480445
44.

Challenge of informing patient decision making: what can we tell patients considering long-term mechanical circulatory support about outcomes, daily life, and end-of-life issues?

Boothroyd LJ, Lambert LJ, Ducharme A, Guertin JR, Sas G, Charbonneau É, Carrier M, Cecere R, Morin JE, Bogaty P.

Circ Cardiovasc Qual Outcomes. 2014 Jan;7(1):179-87. doi: 10.1161/CIRCOUTCOMES.113.000243. Epub 2014 Jan 14. Review. No abstract available.

PMID:
24425705
45.

Evaluation of the right ventricle: comparison of gated blood-pool single photon electron computed tomography and echocardiography with cardiac magnetic resonance.

Anderson K, Prylutska H, Ducharme A, Finnerty V, Grégoire J, Marcotte F, Harel F.

Int J Cardiol. 2014 Jan 15;171(1):1-8. doi: 10.1016/j.ijcard.2013.11.031. Epub 2013 Nov 25.

PMID:
24331119
46.

Should eligibility for heart transplantation be a requirement for left ventricular assist device use? Recommendations based on a systematic review.

Boothroyd LJ, Lambert LJ, Sas G, Guertin JR, Ducharme A, Charbonneau É, Carrier M, Cecere R, Morin JE, Bogaty P.

Can J Cardiol. 2013 Dec;29(12):1712-20. doi: 10.1016/j.cjca.2013.05.014. Epub 2013 Aug 23. Review.

PMID:
23978595
47.

Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial.

Thibault B, Harel F, Ducharme A, White M, Ellenbogen KA, Frasure-Smith N, Roy D, Philippon F, Dorian P, Talajic M, Dubuc M, Guerra PG, Macle L, Rivard L, Andrade J, Khairy P; LESSER-EARTH Investigators.

Circulation. 2013 Feb 26;127(8):873-81. doi: 10.1161/CIRCULATIONAHA.112.001239. Epub 2013 Feb 6.

PMID:
23388213
48.

An unusual case of giant cell myocarditis missed in a Heartmate-2 left ventricle apical-wedge section: a case report and review of the literature.

Anderson K, Carrier M, Romeo P, Pelletier GB, Liszkowski M, Racine N, White M, Ducharme A.

J Cardiothorac Surg. 2013 Jan 17;8:12. doi: 10.1186/1749-8090-8-12.

49.

The 2012 Canadian Cardiovascular Society heart failure management guidelines update: focus on acute and chronic heart failure.

McKelvie RS, Moe GW, Ezekowitz JA, Heckman GA, Costigan J, Ducharme A, Estrella-Holder E, Giannetti N, Grzeslo A, Harkness K, Howlett JG, Kouz S, Leblanc K, Mann E, Nigam A, O'Meara E, Rajda M, Steinhart B, Swiggum E, Le VV, Zieroth S, Arnold JM, Ashton T, D'Astous M, Dorian P, Haddad H, Isaac DL, Leblanc MH, Liu P, Rao V, Ross HJ, Sussex B.

Can J Cardiol. 2013 Feb;29(2):168-81. doi: 10.1016/j.cjca.2012.10.007. Epub 2012 Nov 30. Review.

PMID:
23201056
50.

Mineralocorticoid receptor antagonists and cardiovascular mortality in patients with atrial fibrillation and left ventricular dysfunction: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.

O'Meara E, Khairy P, Blanchet MC, de Denus S, Pedersen OD, Levesque S, Talajic M, Ducharme A, White M, Racine N, Rouleau JL, Tardif JC, Roy D; AF-CHF investigators.

Circ Heart Fail. 2012 Sep 1;5(5):586-93. Epub 2012 Jul 12.

PMID:
22798522

Supplemental Content

Loading ...
Support Center